ELUT
ELUT
NASDAQ · Biotechnology

Elutia Inc

$0.81
-0.01 (-1.20%)
As of Sep 28, 10:31 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,266.7% upside
Low Target $6.75
Average Target $11.07
High Target $12.78
Current Price $0.81
Current
$0.81
Target
$11.07
$6.75 $11.07 avg $12.78
Scenario Analysis
Bear Case
$6.75
733.3%
Low target
Base Case
$11.07
+1,266.7%
Avg target
Bull Case
$12.78
+1,477.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$1.39
-41.5% from high
52-Week Low
$0.50
+62.0% from low
Target vs 52W High
$11.07
+699.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%